Biotech companies in the United States by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Scholar Rock Holding leads the 20 biotech companies in the United States ranked by short interest, at 19.2%, ahead of Twist Bioscience (14.4%) and Kodiak Sciences (12.4%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Scholar Rock Holding19.2%
Median
9.77%
Combined market value
CHF 618.7B
Countries
1

Market values as of .

United States
All sectors
Biotech
CHF
Clear filters
Biotech companies in the United States by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Scholar Rock HoldingSRRK · Health Care19.2%CHF 5.2BCHF 42.40 4.94% up 26% up United States
2Twist BioscienceTWST · Health Care14.4%CHF 6.4BCHF 93.96 4.07% down 346% up United States
3Kodiak SciencesKOD · Health Care12.4%CHF 5.4BCHF 82.41 0.09% up 399% up United States
4Halozyme TherapeuticsHALO · Health Care12.0%CHF 8.9BCHF 78.32 2.88% down 39% up United States
5ImmunityBioIBRX · Health Care11.9%CHF 5.9BCHF 5.53 1.94% down 232% up United States
6RepligenRGEN · Health Care11.0%CHF 9.2BCHF 143.35 1.38% down 12% up United States
7ExelixisEXEL · Health Care10.5%CHF 13.5BCHF 55.42 3.60% down 63% up United States
8CG OncologyCGON · Health Care10.3%CHF 6.2BCHF 68.94 2.38% up 97% up United States
9Krystal BiotechKRYS · Health Care10.3%CHF 7.9BCHF 265.86 0.15% up 54% up United States
10Kymera TherapeuticsKYMR · Health Care9.84%CHF 8.6BCHF 100.50 1.44% down 87% up United States
11VaxcytePCVX · Health Care9.70%CHF 7.8BCHF 49.13 0.27% down 23% up United States
12ImmunovantIMVT · Health Care8.96%CHF 5.7BCHF 27.38 1.96% down 46% up United States
13ModernaMRNA · Health Care8.20%CHF 67.9BCHF 167.80 1.29% up 780% up United States
14Adaptive BiotechnologiesADPT · Health Care7.09%CHF 3.8BCHF 23.61 1.44% down 74% up United States
15Revolution MedicinesRVMD · Health Care6.05%CHF 29BCHF 134.21 0.24% down 129% up United States
16Neurocrine BiosciencesNBIX · Health Care5.83%CHF 13.3BCHF 131.82 3.85% down 17% up United States
17Bio-TechneTECH · Health Care4.90%CHF 9.6BCHF 61.20 0.07% down 24% up United States
18BiogenBIIB · Health Care3.69%CHF 30.8BCHF 208.04 1.70% down 49% up United States
19AmgenAMGN · Health Care2.33%CHF 199.8BCHF 369.40 1.14% down 32% up United States
20Gilead SciencesGILD · Health Care1.72%CHF 173.9BCHF 140.19 1.45% down 35% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8418 CHF).

Questions and answers

Which biotech companies in the United States rank first by short interest?

Scholar Rock Holding (19.2%), Twist Bioscience (14.4%) and Kodiak Sciences (12.4%) are the top three of the 20 biotech companies in the United States ranked by short interest as of the 30 Oct 2026 settlement date.

How many biotech companies in the United States are in this ranking?

20 are ranked by short interest.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by short interest have a combined market value of CHF 618.7B as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Biotech companies in the United States by short interest”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.